Related Experiment Video
Updated: Aug 13, 2026

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
Getting pumped about heart failure
1Center for Cardiovascular Research, Division of Cardiology, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
Abstract:
Heart failure is a clinical syndrome caused by dysregulated calcium handling and abnormal cardiac pumping capacity. Wahlquist et al. (2014) show that upregulation of microRNA-25 impairs calcium handling leading to pump dysfunction and that targeting microRNA-25 using antisense oligonucleotides reverses pump dysfunction and improves survival in mice with heart failure.
Insights
Targeting microRNA-25 with antisense oligonucleotides reversed heart failure pump dysfunction in mice. This approach improved cardiac function and survival by restoring proper calcium handling in heart muscle cells.
Area of Science:
- Cardiovascular Science
- Molecular Biology
- Genetics
Background:
- Heart failure is a syndrome characterized by impaired cardiac pumping capacity.
- Dysregulated calcium handling within cardiomyocytes is a key mechanism underlying heart failure.
- MicroRNAs play critical roles in regulating cardiac function.
Purpose of the Study:
- To investigate the role of microRNA-25 in cardiac calcium handling and pump function.
- To determine if targeting microRNA-25 can ameliorate heart failure phenotypes in a mouse model.
Main Methods:
- Utilized a mouse model of heart failure.
- Assessed cardiac calcium handling and contractility.
- Administered antisense oligonucleotides targeting microRNA-25.
Main Results:
- Upregulation of microRNA-25 was found to impair cardiac calcium handling and lead to pump dysfunction.
- Antisense oligonucleotide treatment targeting microRNA-25 reversed cardiac pump dysfunction.
- Targeting microRNA-25 improved survival rates in mice with heart failure.
Conclusions:
- MicroRNA-25 is a critical regulator of cardiac calcium handling and pump function.
- Antisense oligonucleotide-mediated inhibition of microRNA-25 represents a potential therapeutic strategy for heart failure.
- Restoring normal calcium handling through microRNA targeting offers a promising avenue for improving heart failure outcomes.
Related Concept Videos
Pathophysiology of Heart Failure
Heart Failure I: Introduction
Heart Failure II: Pathophysiology
Heart Failure III: Clinical Manifestations
Heart Failure V: Medical Management
Heart Failure VII: Nursing Interventions

